Cystic Kidney Disease
Cystic kidney disease is a genetic disorder where fluid-filled sacs or cysts develop on the kidneys. These cysts gradually enlarge, leading to compression of healthy kidney tissues, impairing their ability to perform their necessary functions. The two most common types of cystic kidney disease are autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD). ADPKD is the most common form of cystic kidney disease and mainly affects adults. The disease is characterized by multiple cysts that grow on the kidneys over time, leading to kidney enlargement and a gradual loss of kidney function. Symptoms typically develop in adulthood and include high blood pressure, back pain, and urinary tract infections. ARPKD is a rare form of cystic kidney disease that mainly affects children. This type of cystic kidney disease is caused by a genetic mutation that leads to the formation of cysts in the kidneys and other organs, including the liver and lungs. ARPKD can lead to severe complications such as liver disease, pulmonary hypertension and kidney failure in early childhood. Treatment options for cystic kidney disease include blood pressure control, pain management, and, in severe cases, kidney transplant. There is no cure for cystic kidney disease, and management mainly focuses on slowing down the disease progression and managing associated complications. Preventive measures for cystic kidney disease involve genetic counseling and screening. Screening and genetic counseling help identify individuals with a high risk of developing cystic kidney disease and ensure that they receive appropriate care, including regular monitoring of their kidney function and managing any associated complications. Additionally, individuals with a family history of cystic kidney disease should be screened early and regularly to help detect the condition early on when treatment is most effective.
← Journal of Preventive Medicine And Care